Preguntas de entrevista investigadas, descripción del proceso y señales de dificultad en Moderna, compiladas por el equipo de investigación de Primly.
6 experienciasDificultad 3.8/5Pharma / mRNA
Regulatory Affairs Manager
virtual
· Dificultad 4/5
Candidates report starting with a recruiter screen to confirm regulatory scope (US, EU, global), therapeutic area alignment, and experience with submissions and health authority interactions, usually 30 minutes. The next stage is typically a hiring manager interview focused on strategy, stakeholder management across CMC, clinical, safety, and labeling, and examples of navigating accelerated timelines. Many candidates then complete a multi-interviewer virtual loop with 4 to 6 conversations including Regulatory CMC, Clinical Regulatory, project/program leadership, and sometimes Quality or Pharmacovigilance, often scheduled in one day or split across two days. A common feature is a practical case discussion rather than a formal take-home, such as outlining an approach to an upcoming meeting with FDA/EMA or responding to an information request while protecting the program timeline. Final steps often include an interview with a senior regulatory leader to probe judgment, risk framing, and how the candidate influences without authority in a fast-moving environment, with end-to-end timing commonly around 3 to 6 weeks.
Explain how you would build a regulatory strategy for an mRNA program moving from early clinical to pivotal, including major submission milestones and key risks you would flag.
Describe a time you had to align CMC, clinical, and safety stakeholders on a regulatory position under significant time pressure. What tradeoffs did you make?
A health authority asks for additional comparability data after a process change. How would you assess the request and propose a path forward with CMC and Quality?
What does a strong briefing package look like for a Type B meeting, and how do you decide what to push for versus defer?
How do you communicate regulatory risk in a way that enables fast decisions rather than slowing a team down?
Quality Assurance Specialist
virtual
· Dificultad 3/5
Candidates report a recruiter phone screen first, typically 20 to 30 minutes, focused on eligibility to work, location expectations, motivation for Moderna’s mission, and a high-level review of GMP exposure. The next step is commonly a hiring manager video interview, 45 to 60 minutes, testing fundamentals of pharma quality systems (deviations, CAPA, change control, documentation practices) and how the candidate handles urgency in a regulated environment. Many processes then add a virtual panel loop of 3 to 5 interviews over half a day, with cross-functional partners from Quality Operations, Manufacturing, Supply Chain, or Technical Operations. Interviewers often ask for concrete examples of documentation rigor, decision-making under ambiguity, and how the candidate escalates quality risks while supporting speed. Some candidates report a final conversation with a senior quality leader or HR partner to confirm level, culture fit, and logistics, with an overall timeline of about 2 to 5 weeks depending on site needs and headcount urgency.
Walk through how you would document and triage a deviation discovered on the manufacturing floor, including what information you would collect first and who you would involve.
Describe a time you had to stop or slow down work due to a compliance concern. How did you communicate it, and what was the outcome?
If a batch record has a missing entry or unclear correction, what is your next step and what would you avoid doing?
How have you used CAPA in the past, and how do you distinguish between immediate correction and root-cause corrective action?
Moderna is known for moving quickly. How would you balance speed with quality expectations in day-to-day decisions?
Software Engineer
virtual
· Dificultad 3/5
Recruiter screen, coding phone, virtual onsite with coding, system design, deep-dive, and behavioral.
Tell me about owning a feature with clinical-trial implications.
Describe debugging a regulatory-impacted issue.
Walk me through how you'd design a clinical-data platform.
How do you partner with clinical teams on a feature?